Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $43.4950 (-6.14%) ($43.4950 - $43.4950) on Thu. Mar. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.67% (three month average) | RSI | 51 | Latest Price | $43.4950(-6.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(59%) IBUY(58%) IPO(56%) | Factors Impacting EDIT price | EDIT will decline at least -3.335% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-13%) TBT(-7%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.335% (StdDev 6.67%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $46.05 | 5 Day Moving Average | $45.89(-5.22%) | 10 Day Moving Average | $45.18(-3.73%) | 20 Day Moving Average | $46.05(-5.55%) | To recent high | -52.2% | To recent low | 8.2% | Market Cap | $2.701b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |